These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3885290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
    Meiselas KD, Spencer EK, Oberfield R, Peselow ED, Angrist B, Campbell M.
    J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.
    Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE.
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
    Perry R, Campbell M, Adams P, Lynch N, Spencer EK, Curren EL, Overall JE.
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Should autistic children be treated with haloperidol?
    Ornitz EM.
    Am J Psychiatry; 1985 Jul; 142(7):883-4. PubMed ID: 3893168
    [No Abstract] [Full Text] [Related]

  • 7. Repeated episodes of neuroleptic-related dyskinesias in autistic children.
    Malone RP, Ernst M, Godfrey KA, Locascio JJ, Campbell M.
    Psychopharmacol Bull; 1991 Jul; 27(2):113-7. PubMed ID: 1681562
    [Abstract] [Full Text] [Related]

  • 8. Tourette-like symptoms associated with neuroleptic therapy in an autistic child.
    Perry R, Nobler MS, Campbell M.
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):93-6. PubMed ID: 2914842
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S, Erfani S, Mohammadi MR, Tehrani-Doost M, Amini H, Gudarzi SS, Yasamy MT.
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [Abstract] [Full Text] [Related]

  • 11. A study of haloperidol in young autistic children: a within-subjects design using objective rating scales.
    Cohen IL, Campbell M, Posner D.
    Psychopharmacol Bull; 1980 Jul; 16(3):63-5. PubMed ID: 7403407
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic-related dyskinesias and stereotypies in autistic children: videotaped ratings.
    Shay J, Sanchez LE, Cueva JE, Armenteros JL, Overall JE, Campbell M.
    Psychopharmacol Bull; 1993 Jul; 29(3):359-63. PubMed ID: 7907183
    [Abstract] [Full Text] [Related]

  • 13. A comparison of haloperidol, behavior therapy, and their interaction in autistic children [proceedings].
    Campbell M, Anderson LT, Meier M.
    Psychopharmacol Bull; 1979 Apr; 15(2):84-6. PubMed ID: 373009
    [No Abstract] [Full Text] [Related]

  • 14. Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.
    Armenteros JL, Adams PB, Campbell M, Eisenberg ZW.
    Psychopharmacol Bull; 1995 Apr; 31(2):363-9. PubMed ID: 7491393
    [Abstract] [Full Text] [Related]

  • 15. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [Abstract] [Full Text] [Related]

  • 16. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Ernst M, Devi L, Silva RR, Gonzalez NM, Small AM, Malone RP, Campbell M.
    Psychopharmacol Bull; 1993 Apr; 29(2):221-7. PubMed ID: 8290669
    [Abstract] [Full Text] [Related]

  • 17. Haloperidol withdrawal and weight changes in autistic children.
    Silva RR, Malone RP, Anderson LT, Shay J, Campbell M.
    Psychopharmacol Bull; 1993 Apr; 29(2):287-91. PubMed ID: 8290679
    [Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E, Shapiro AK.
    Adv Neurol; 1982 Apr; 35():413. PubMed ID: 6959518
    [No Abstract] [Full Text] [Related]

  • 19. [The effects of neuroleptics on tardive dyskinesias. A video-controlled, randomized study of chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden].
    Povlsen UJ, Noring U, Meidahl B, Korsgaard S, Waehrens J, Gerlach J.
    Ugeskr Laeger; 1987 Jun 15; 149(25):1682-5. PubMed ID: 3299955
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE, Ferguson DG, Cullari S.
    Psychopharmacol Bull; 1981 Jan 15; 17(1):122-3. PubMed ID: 7232641
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.